New hope for Women's hearts after pregnancy complication
NCT ID NCT07238400
Summary
This study aims to see if the medication eplerenone improves heart blood flow and structure better than the medication chlorthalidone in women who had preeclampsia during pregnancy and now have ongoing high blood pressure. About 90 participants will take one of the two study drugs daily for 48 weeks while researchers measure their heart function with scans and ultrasounds. The goal is to find a better long-term treatment strategy to reduce future heart disease risk in this specific group of women.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.